During the corresponding time, Catalent Inc recorded a revenue increase by 4.18 % year on year, sequentially revenue fell by -21.37 %. While revenue at the Catalent Inc 's corporate clients
Catalent Inc's Comment on Sales, Marketing and Customers
The company produces nearly 70 billion unit doses annually of pharmaceutical and consumer health products, representing approximately one in every 28 unit doses consumed globally. In fiscal 2024, it conducted business with 88 of the top 100 branded drug and consumer health marketers and 82 of the top 100 biologics marketers worldwide. Key customers include Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Haleon, Moderna, Novo Nordisk, Pfizer, and Sarepta Therapeutics. The company maintains long-term relationships with customers, supporting products throughout their lifecycle from pre-clinical development to mature commercial stages. Its services encompass innovative product development, quality manufacturing, and technical support, with technologies integrated into customers' final formulations and regulatory filings to ensure sustained supply partnerships.
Catalent Inc’s Comment on Sales, Marketing and Customers
The company produces nearly 70 billion unit doses annually of pharmaceutical and consumer health products, representing approximately one in every 28 unit doses consumed globally. In fiscal 2024, it conducted business with 88 of the top 100 branded drug and consumer health marketers and 82 of the top 100 biologics marketers worldwide. Key customers include Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Haleon, Moderna, Novo Nordisk, Pfizer, and Sarepta Therapeutics. The company maintains long-term relationships with customers, supporting products throughout their lifecycle from pre-clinical development to mature commercial stages. Its services encompass innovative product development, quality manufacturing, and technical support, with technologies integrated into customers' final formulations and regulatory filings to ensure sustained supply partnerships.
Sources:
Catalent Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Catalent Inc’s corporate clients.
For your research, we’ve provided 9 tables on Catalent Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
100.1 %